Loading clinical trials...
Loading clinical trials...
Quantification of Calcinosis Cutis Disease Burden in Patients With Systemic Sclerosis Using Computed Tomography Images
Conditions
Interventions
Sodium Thiosulfate (STS)
Sodium Thiosulfate Injection
Locations
1
United States
Yale Scleroderma Program
New Haven, Connecticut, United States
Start Date
October 14, 2025
Primary Completion Date
July 1, 2026
Completion Date
July 1, 2026
Last Updated
February 17, 2026
NCT07526350
NCT07413341
NCT07305116
NCT06991114
NCT06792344
NCT07292961
Lead Sponsor
Yale University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions